UNSPSC 85702318: Supplement sacrum with autologous tissue substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement sacrum with autologous tissue substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0QU137Z

UNSPSC 85702318 Supplement sacrum with autologous tissue substitute, percutaneous approach is a Commodity code for a specific orthopedic surgical procedure, but state and local government procurement activity under this code shows no alignment between the code's nominal clinical scope and the actual work being solicited. The recent opportunities posted under this code span inmate healthcare services management, pharmacy benefit administration, virtual primary and urgent care platforms, peer support services for behavioral health workers, and fire department medical direction — none of which involve sacral augmentation or autologous tissue grafting. The code appears to be a misclassification artifact in the state and local sourcing system rather than a meaningful procurement category. No opportunities in the source reflect the work the code nominally describes.

The issuing bodies include county departments of correction (Muscogee County, Georgia), county benefits administration (Collier County, Florida), county health plan operations (Monroe County, Florida), county behavioral health services (San Mateo County, California), and municipal emergency services (Santa Monica, California). Geographic activity spans Florida, Georgia, and California. The opportunities are predominantly RFPs with response deadlines ranging from April through July 2026, but they represent health administration, employee benefits, and emergency services contracting rather than orthopedic implant procurement. Business development professionals should treat this code as inactive for its stated scope and flag the misclassification with state and local procurement offices when evaluating orthopedic device or tissue graft opportunities.